Questions About Cancer? 1-800-4-CANCER

All News Releases

Mayo and NCI researchers find that trastuzumab continues to show life for HER2-positve early stage breast cancer
NCI Cancer Center News
(Posted: 10/21/2014) - After following breast cancer patients for an average of eight-plus years, researchers say that adding trastuzumab (Herceptin) to chemotherapy significantly improved the overall and disease-free survival of women with early stage HER2-positive breast cancer.

UCSF researchers find a genetic variant that may protect some Latina women from breast cancer
NCI Cancer Center News
(Posted: 10/20/2014) - An international research collaboration led by UC San Francisco researchers has identified a genetic variant common in Latina women that may protect against breast cancer.

University of Arizona researchers find that a good diet before diagnosis is linked with lower mortality among ovarian cancer survivors
NCI Cancer Center News
(Posted: 10/20/2014) - Prediagnosis diet quality was associated with mortality and may have a protective effect after ovarian cancer, according to a new study published October 14 in the JNCI: Journal of the National Cancer Institute.

Washington U researchers find that many older people have mutations linked to leukemia, lymphoma in their blood cells
NCI Cancer Center News
(Posted: 10/20/2014) - At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University School of Medicine in St. Louis.

MD Anderson researchers compare treatments, survival benefits for early-stage lung cancer
NCI Cancer Center News
(Posted: 10/20/2014)

U of Pittsburgh researchers find stem cells in mice in the esophagus
NCI Cancer Center News
(Posted: 10/17/2014) - In an animal study published online today in Cell Reports, researchers report findings from mice that could lead to new insights into the development and treatment of esophageal cancer and the precancerous condition known as Barrett's esophagus.

UCSF mouse and human studies indicate that cancer prognosis may be related to newly identified immune cell
NCI Cancer Center News
(Posted: 10/17/2014) - A newly discovered population of immune cells in tumors is associated with less severe cancer outcomes in humans, and may have therapeutic potential, according to a new UC San Francisco study of 3,600 human tumors of 12 types, as well as mouse experiments.

Duke researchers find that prostate cancer’s penchant for copper may be a fatal flaw
NCI Cancer Center News
(Posted: 10/15/2014) - Researchers at Duke Medicine have found a way to kill prostate cancer cells by delivering a trove of copper along with a drug that selectively destroys the diseased cells brimming with the mineral, leaving non-cancer cells healthy.

U of Chicago researchers find that SIRT6 prevents some cancers but promotes sun-induced skin cancer
NCI Cancer Center News
(Posted: 10/15/2014) - SIRT6 -- a protein that inhibits the growth of liver and colon cancers -- can promote the development of skin cancers by turning on an enzyme that increases inflammation, proliferation and survival of sun-damaged skin cells.

Stanford researchers find that drug may prevent development of invasive bladder cancer
NCI Cancer Center News
(Posted: 10/14/2014) - A drug that activates targets of the hedgehog signaling pathway, which is lost when bladder cancer invades, could prevent the progression of the disease in humans.

< Previous  9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29  Next >